Clinical trial · Observational
VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer
VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung cancer-a Registry Study
NCT01707888CI-TRIAL-00016718unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Surgery may be the best treatment choice for early stage non-small cell lung cancer. And VATS major lung resection have been preferred as a standard radical procedure for early stage non-small cell lung cancer (NSCLC).This study aim to investigate the outcome of VATS major lung resection for lung cancer as a real-world study in china.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Thoracoscopy/VATS | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- major lung resection
- description
- Patients undergo major lung resection by thoracoscopy/VATS.
- interventionNames
- Procedure: Thoracoscopy/VATS
Primary outcomes (1)
- measure
- morbidity and mortility rate
- timeFrame
- 3 moths
- description
- perioperative complications and death rates of the group
Secondary outcomes (7)
- measure
- Disease-free survival
- timeFrame
- 3y
- description
- To evaluate Disease Free Survival (DFS) of the group.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Preoperative criteria: i) non-small cell lung cancer is suspected, ii) clinical stage I/II (3) Intraoperative criteria: i) Histologically confirmed NSCLC, ii) resected by VATS or converted open lobectomy,sleeve lobectomy or pneumonectomy and nodal dissection/sampling. (4) No prior ipsilateral thoracotomy (prior diagnostic thoracoscopy is allowed). (5) No prior chemotherapy or radiation therapy for any malignant diseases. (6) Expected postoperative FEV1.0\>=800 mL and PaO2\>=65 torr. (7) Performance status of 0 or 1. (8) Sufficient organ functions. (9) Written informed consent. Exclusion Criteria: 1. Active bacterial or fungous infection. 2. Simultaneous or metachronous (within the past 5 years) double cancers. 3. Women during pregnancy or breast-feeding. 4. Interstitial pneumonitis, pulmonary fibrosis, or severe pulmonary emphysema. 5. Psychosis. 6. Systemic steroids medication. 7. Uncontrollable diabetes mellitus. 8. Uncontrollable hypertension. 9. History of severe heart disease, heart failure, myocardial infarction within the past 6 months or attack of angina pectoris within the past 6 months.
References
Publications (0)
Data not yet available
No reference posted for this study.